{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2", "clinical trials drugs", "cytokine storm", "immunomodulatory", "natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37124230", "DateRevised": {"Year": "2023", "Month": "05", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "12"}], "Language": ["eng"], "ELocationID": ["1111329", "10.3389/fphar.2023.1111329"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now.", "Pagination": {"StartPage": "1111329", "MedlinePgn": "1111329"}, "Abstract": {"AbstractText": ["A novel coronavirus strain (COVID-19) caused severe illness and mortality worldwide from 31 December 2019 to 21 March 2023. As of this writing, 761,071,826 million cases have been diagnosed worldwide, with 6,879,677 million deaths accorded by WHO organization and has spread to 228 countries. The number of deaths is closely connected to the growth of innate immune cells in the lungs, mainly macrophages, which generate inflammatory cytokines (especially IL-6 and IL-1\u03b2) that induce \"cytokine storm syndrome\" (CSS), multi-organ failure, and death. We focus on promising natural products and their biologically active chemical constituents as potential phytopharmaceuticals that target virus-induced pro-inflammatory cytokines. Successful therapy for this condition is currently rare, and the introduction of an effective vaccine might take months. Blocking viral entrance and replication and regulating humoral and cellular immunity in the uninfected population are the most often employed treatment approaches for viral infections. Unfortunately, no presently FDA-approved medicine can prevent or reduce SARS-CoV-2 access and reproduction. Until now, the most important element in disease severity has been the host's immune response activation or suppression. Several medicines have been adapted for COVID-19 patients, including arbidol, favipiravir, ribavirin, lopinavir, ritonavir, hydroxychloroquine, chloroquine, dexamethasone, and anti-inflammatory pharmaceutical drugs, such as tocilizumab, glucocorticoids, anakinra (IL-1\u03b2 cytokine inhibition), and siltuximab (IL-6 cytokine inhibition). However, these synthetic medications and therapies have several side effects, including heart failure, permanent retinal damage in the case of hydroxyl-chloroquine, and liver destruction in the case of remdesivir. This review summarizes four strategies for fighting cytokine storms and immunomodulatory deficiency induced by COVID-19 using natural product therapy as a potential therapeutic measure to control cytokine storms."], "CopyrightInformation": "Copyright \u00a9 2023 Mohammed."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Giza, Egypt."}], "LastName": "Mohammed", "ForeName": "Mona A", "Initials": "MA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmad J., Khan I., Blundell R., Azzopardi J., Mahomoodally M. F. (2020). Stevia rebaudiana Bertoni.: An updated review of its health benefits, industrial applications and safety. Trends Food Sci. Technol. 100, 177\u2013189. 10.1016/j.tifs.2020.04.030", "ArticleIdList": ["10.1016/j.tifs.2020.04.030"]}, {"Citation": "al-Kuraishy, al-Fakhrany, Elekhnawy E., al-Gareeb A. I., Alorabi M., de Waard M., et al. (2022). Traditional herbs against COVID-19: Back to old weapons to combat the new pandemic. Eur. J. Med. Res. 27, 186. 10.1186/s40001-022-00818-5", "ArticleIdList": ["10.1186/s40001-022-00818-5", "PMC9510171", "36154838"]}, {"Citation": "Am Lee S., Lee S. H., Kim J. Y., Lee W. S. (2019). Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model. J. Thorac. Dis. 11, 1287\u20131302. 10.21037/jtd.2019.04.14", "ArticleIdList": ["10.21037/jtd.2019.04.14", "PMC6531684", "31179071"]}, {"Citation": "Armanini D., Fiore C., Bielenberg J., Sabbadin C., Bordin L. (2020). Coronavirus-19: Possible therapeutic implications of spironolactone and dry extract of Glycyrrhiza glabra L.(Licorice). Front. Pharmacol. 11, 558418. 10.3389/fphar.2020.558418", "ArticleIdList": ["10.3389/fphar.2020.558418", "PMC7642094", "33192504"]}, {"Citation": "Arreola R., Quintero-Fabi\u00e1N S., L\u00f3PEZ-Roa R. I., Flores-Gutierrez E. O., Reyes-Grajeda J. P., Carrera-Quintanar L., et al. (2015). Immunomodulation and anti-inflammatory effects of garlic compounds. J. Immunol. Res., 2015, 401630, 10.1155/2015/401630", "ArticleIdList": ["10.1155/2015/401630", "PMC4417560", "25961060"]}, {"Citation": "Atal S., Fatima Z. (2020). IL-6 inhibitors in the treatment of serious COVID-19: A promising therapy? Pharm. Med. 34, 223\u2013231. 10.1007/s40290-020-00342-z", "ArticleIdList": ["10.1007/s40290-020-00342-z", "PMC7292936", "32535732"]}, {"Citation": "Attia G. H., Marrez D. A., Mohammed M. A., Albarqi H. A., Ibrahim A. M., Raey M. A. E. (2021). Synergistic effect of Mandarin peels and hesperidin with sodium nitrite against some food pathogen microbes. Molecules 26, 3186. 10.3390/molecules26113186", "ArticleIdList": ["10.3390/molecules26113186", "PMC8199405", "34073447"]}, {"Citation": "Babaei F., Nassiri\u2010Asl M., Hosseinzadeh H. (2020). Curcumin (a constituent of turmeric): New treatment option against COVID\u201019. Food Sci. Nutr. 8, 5215\u20135227. 10.1002/fsn3.1858", "ArticleIdList": ["10.1002/fsn3.1858", "PMC7590269", "33133525"]}, {"Citation": "Bachiega T. F., de Sousa J. P. B., Bastos J. K., Sforcin J. M. (2012). Clove and eugenol in noncytotoxic concentrations exert immunomodulatory/anti-inflammatory action on cytokine production by murine macrophages. J. Pharm. Pharmacol. 64, 610\u2013616. 10.1111/j.2042-7158.2011.01440.x", "ArticleIdList": ["10.1111/j.2042-7158.2011.01440.x", "22420667"]}, {"Citation": "Bailly C., Vergoten G. (2020). Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol. Ther. 214, 107618. 10.1016/j.pharmthera.2020.107618", "ArticleIdList": ["10.1016/j.pharmthera.2020.107618", "PMC7311916", "32592716"]}, {"Citation": "Balkrishna A., Pokhrel S., Singh J., Varshney A. 2020. Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor."}, {"Citation": "Balkrishna A., Pokhrel S., Varshney A. (2021). Tinocordiside from Tinospora cordifolia (Giloy) may curb SARS-CoV-2 contagion by disrupting the electrostatic interactions between host ACE2 and viral S-protein receptor binding domain. Comb. Chem. High Throughput Screen. 24, 1795\u20131802. 10.2174/1386207323666201110152615", "ArticleIdList": ["10.2174/1386207323666201110152615", "33172372"]}, {"Citation": "Banerjee A., Czinn S. J., Reiter R. J., Blanchard T. G. (2020). Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19. Life Sci. 255, 117842. 10.1016/j.lfs.2020.117842", "ArticleIdList": ["10.1016/j.lfs.2020.117842", "PMC7245231", "32454157"]}, {"Citation": "Bansal M., Singh N., Pal S., Dev I., Ansari K. M. (2018). Chemopreventive role of dietary phytochemicals in colorectal cancer. Adv. Mol. Toxicol. 12, 69\u2013121."}, {"Citation": "Banu N., Panikar S. S., Leal L. R., Leal A. R. (2020). Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome: Therapeutic implications. Life Sci. 256, 117905. 10.1016/j.lfs.2020.117905", "ArticleIdList": ["10.1016/j.lfs.2020.117905", "PMC7832382", "32504757"]}, {"Citation": "Barboza J. N., Da Silva Maia Bezerra Filho C., Silva R. O., Medeiros J. V. R., de Sousa D. P. (2018). An overview on the anti-inflammatory potential and antioxidant profile of eugenol. Oxidative Med. Cell. Longev.", "ArticleIdList": ["PMC6217746", "30425782"]}, {"Citation": "Barone M., Ucciferri C., Cipollone G., Mucilli F. (2020). Recombinant human angiotensin-converting enzyme 2 and COVID-19 acute respiratory distress syndrome: A theoretical or a real resource. Ejmo 4, 139\u2013140. 10.14744/ejmo.2020.47992", "ArticleIdList": ["10.14744/ejmo.2020.47992"]}, {"Citation": "Ben\u2010Zvi I., Kukuy O., Giat E., Pras E., Feld O., Kivity S., et al. (2017). Anakinra for colchicine\u2010resistant familial mediterranean fever: A randomized, double\u2010blind, placebo\u2010controlled trial. Arthritis & Rheumatology 69, 854\u2013862. 10.1002/art.39995", "ArticleIdList": ["10.1002/art.39995", "27860460"]}, {"Citation": "Bergsbaken T., Fink S. L., Cookson B. T. (2009). Pyroptosis: Host cell death and inflammation. Nat. Rev. Microbiol. 7, 99\u2013109. 10.1038/nrmicro2070", "ArticleIdList": ["10.1038/nrmicro2070", "PMC2910423", "19148178"]}, {"Citation": "Blaszczak A., Trinidad J. C., Cartron A. M. (2020). Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations. J. Am. Acad. Dermatology 83, e31. 10.1016/j.jaad.2020.04.030", "ArticleIdList": ["10.1016/j.jaad.2020.04.030", "PMC7151529", "32283230"]}, {"Citation": "Bogoch I. I., Watts A., Thomas-Bachli A., Huber C., Kraemer M. U., Khan K. (2020). Potential for global spread of a novel coronavirus from China. J. travel Med. 27, taaa011. taaa011. 10.1093/jtm/taaa011", "ArticleIdList": ["10.1093/jtm/taaa011", "PMC7074660", "31985790"]}, {"Citation": "Borlinghaus J., Albrecht F., Gruhlke M. C., Nwachukwu I. D., Slusarenko A. J. (2014). Allicin: Chemistry and biological properties. Molecules 19, 12591\u201312618. 10.3390/molecules190812591", "ArticleIdList": ["10.3390/molecules190812591", "PMC6271412", "25153873"]}, {"Citation": "Buagaew A., Poomipark N. (2020). Protective effect of piperine from Piper chaba fruits on LPS-induced inflammation in human intestinal cell line. J. Med. Plants Res. 14, 438\u2013444. 10.5897/jmpr2020.6996", "ArticleIdList": ["10.5897/jmpr2020.6996"]}, {"Citation": "Bull-Otterson L., Gray E. B., Budnitz D. S., Strosnider H. M., Schieber L. Z., Courtney J., et al. (2020). Hydroxychloroquine and chloroquine prescribing patterns by provider specialty following initial reports of potential benefit for COVID-19 treatment\u2014United States, january\u2013june 2020. Morb. Mortal. Wkly. Rep. 69, 1210\u20131215. 10.15585/mmwr.mm6935a4", "ArticleIdList": ["10.15585/mmwr.mm6935a4", "PMC7470458", "32881845"]}, {"Citation": "Cabler S. S., French A. R., Orvedahl A. (2020). A cytokine circus with a viral ringleader: SARS-CoV-2-associated cytokine storm syndromes. Trends Mol. Med. 26, 1078\u20131085. 10.1016/j.molmed.2020.09.012", "ArticleIdList": ["10.1016/j.molmed.2020.09.012", "PMC7524648", "33051104"]}, {"Citation": "Cao Z., Fang Y., Lu Y., Tan D., du C., Li Y., et al. (2017). Melatonin alleviates cadmium\u2010induced liver injury by inhibiting the TXNIP\u2010NLRP3 inflammasome. J. Pineal Res. 62, e12389. 10.1111/jpi.12389", "ArticleIdList": ["10.1111/jpi.12389", "28099758"]}, {"Citation": "Caso F., Costa L., Ruscitti P., Navarini L., Del Puente A., Giacomelli R., et al. (2020). Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun. Rev. 19, 102524. 10.1016/j.autrev.2020.102524", "ArticleIdList": ["10.1016/j.autrev.2020.102524", "PMC7271072", "32220633"]}, {"Citation": "Catanzaro M., Fagiani F., Racchi M., Corsini E., Govoni S., Lanni C. (2020). Immune response in COVID-19: Addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct. Target. Ther. 5, 84\u201310. 10.1038/s41392-020-0191-1", "ArticleIdList": ["10.1038/s41392-020-0191-1", "PMC7255975", "32467561"]}, {"Citation": "Cavalli G., de Luca G., Campochiaro C., della-Torre E., Ripa M., Canetti D., et al. (2020). Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: A retrospective cohort study. Lancet Rheumatology 2, e325\u2013e331. 10.1016/S2665-9913(20)30127-2", "ArticleIdList": ["10.1016/S2665-9913(20)30127-2", "PMC7252085", "32501454"]}, {"Citation": "Charles P., Elliott M. J., Davis D., Potter A., Kalden J. R., Antoni C., et al. (1999). Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-\u03b1 therapy in rheumatoid arthritis. J. Immunol. 163, 1521\u20131528. 10.4049/jimmunol.163.3.1521", "ArticleIdList": ["10.4049/jimmunol.163.3.1521", "10415055"]}, {"Citation": "Chekalina N., Burmak Y., Petrov Y., Borisova Z., Manusha Y., Kazakov Y., et al. (2018). Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease. Indian Heart J. 70, 593\u2013597. 10.1016/j.ihj.2018.04.006", "ArticleIdList": ["10.1016/j.ihj.2018.04.006", "PMC6204471", "30392493"]}, {"Citation": "Chen L.-X., He H., Qiu F. (2011). Natural withanolides: An overview. Nat. Product. Rep. 28, 705\u2013740. 10.1039/c0np00045k", "ArticleIdList": ["10.1039/c0np00045k", "21344104"]}, {"Citation": "Chen X., Kang Y., Luo J., Pang K., Xu X., Wu J., et al. (2021). Next-generation sequencing reveals the progression of COVID-19. Front. Cell. Infect. Microbiol. 11, 632490. 10.3389/fcimb.2021.632490", "ArticleIdList": ["10.3389/fcimb.2021.632490", "PMC7991797", "33777844"]}, {"Citation": "Chourasia M., Koppula P. R., Battu A., Ouseph M. M., Singh A. K. (2021). EGCG, a green tea catechin, as a potential therapeutic agent for symptomatic and asymptomatic SARS-CoV-2 infection. Molecules 26, 1200. 10.3390/molecules26051200", "ArticleIdList": ["10.3390/molecules26051200", "PMC7956763", "33668085"]}, {"Citation": "Chousterman B. G., Swirski F. K., Weber G. F. (2017). Cytokine storm and sepsis disease pathogenesis. In Seminars in immunopathology. Springer, 517\u2013528.", "ArticleIdList": ["28555385"]}, {"Citation": "Chowdhury P. (2020). In silico investigation of phytoconstituents from Indian medicinal herb \u2018Tinospora cordifolia (giloy)\u2019against SARS-CoV-2 (COVID-19) by molecular dynamics approach. J. Biomol. Struct. Dyn. 39, 6792\u20136809. 10.1080/07391102.2020.1803968", "ArticleIdList": ["10.1080/07391102.2020.1803968", "PMC7484574", "32762511"]}, {"Citation": "Chugh A., Sehgal I., Khurana N., Verma K., Rolta R., Vats P., et al. (2023). Comparative docking studies of drugs and phytocompounds for emerging variants of SARS-CoV-2. 3 Biotech. 13, 36. 10.1007/s13205-022-03450-6", "ArticleIdList": ["10.1007/s13205-022-03450-6", "PMC9815891", "36619821"]}, {"Citation": "Chung H. Y. (2019). Anti-inflammatory and antioxidant activities of piperine on t. BHP-induced Ac2F cells."}, {"Citation": "Ciampi E., Uribe-San-Martin R., C\u00e1RCAMO C., Cruz J. P., Reyes A., Reyes D., et al. (2020). Efficacy of andrographolide in not active progressive multiple sclerosis: A prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial. BMC Neurol. 20, 1\u201310. 10.1186/s12883-020-01745-w", "ArticleIdList": ["10.1186/s12883-020-01745-w", "PMC7203851", "32380977"]}, {"Citation": "Colafrancesco S., Scrivo R., Barbati C., Conti F., Priori R. (2020). Targeting the immune system for pulmonary inflammation and cardiovascular complications in COVID-19 patients. Front. Immunol. 11, 1439. 10.3389/fimmu.2020.01439", "ArticleIdList": ["10.3389/fimmu.2020.01439", "PMC7324709", "32655577"]}, {"Citation": "Colunga Biancatelli R. M. L., Berrill M., Catravas J. D., Marik P. E. (2020). Quercetin and vitamin C: An experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19). Front. Immunol. 11, 1451. 10.3389/fimmu.2020.01451", "ArticleIdList": ["10.3389/fimmu.2020.01451", "PMC7318306", "32636851"]}, {"Citation": "Coomes E. A., Haghbayan H. (2020). Interleukin\u20106 in COVID\u201019: A systematic review and meta\u2010analysis. Rev. Med. virology 30, 1\u20139. 10.1002/rmv.2141", "ArticleIdList": ["10.1002/rmv.2141", "PMC7460877", "32845568"]}, {"Citation": "Cosenza M., Sacchi S., Pozzi S. (2021). Cytokine release syndrome associated with T-cell-based therapies for hematological malignancies: Pathophysiology, clinical presentation, and treatment. Int. J. Mol. Sci. 22, 7652. 10.3390/ijms22147652", "ArticleIdList": ["10.3390/ijms22147652", "PMC8305850", "34299273"]}, {"Citation": "Culpitt S., Rogers D., Fenwick P., Shah P., de Matos C., Russell R., et al. (2003). Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58, 942\u2013946. 10.1136/thorax.58.11.942", "ArticleIdList": ["10.1136/thorax.58.11.942", "PMC1746526", "14586044"]}, {"Citation": "Cure E., Kucuk A., Cure M. C. (2020). Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19). Rheumatol. Int. 1, 1177\u20131179. 10.1007/s00296-020-04603-7", "ArticleIdList": ["10.1007/s00296-020-04603-7", "PMC7227450", "32415310"]}, {"Citation": "Darwish I., Mubareka S., Liles W. C. (2011). Immunomodulatory therapy for severe influenza. Expert Rev. anti-infective Ther. 9, 807\u2013822. 10.1586/eri.11.56", "ArticleIdList": ["10.1586/eri.11.56", "21810053"]}, {"Citation": "Datta P. K., Liu F., Fischer T., Rappaport J., Qin X. (2020). SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics 10, 7448\u20137464. 10.7150/thno.48076", "ArticleIdList": ["10.7150/thno.48076", "PMC7330865", "32642005"]}, {"Citation": "Dawood F. S., Iuliano A. D., Reed C., Meltzer M. I., Shay D. K., Cheng P.-Y., et al. (2012). Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. Lancet Infect. Dis. 12, 687\u2013695. 10.1016/S1473-3099(12)70121-4", "ArticleIdList": ["10.1016/S1473-3099(12)70121-4", "22738893"]}, {"Citation": "Deftereos S. G., Giannopoulos G., Vrachatis D. A., Siasos G. D., Giotaki S. G., Gargalianos P., et al. (2020). Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: The GRECCO-19 randomized clinical trial. JAMA Netw. open 3, e2013136. 10.1001/jamanetworkopen.2020.13136", "ArticleIdList": ["10.1001/jamanetworkopen.2020.13136", "PMC7315286", "32579195"]}, {"Citation": "Del Valle D. M., Kim-Schulze S., Huang H.-H., Beckmann N. D., Nirenberg S., Wang B., et al. (2020). An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636\u20131643. 10.1038/s41591-020-1051-9", "ArticleIdList": ["10.1038/s41591-020-1051-9", "PMC7869028", "32839624"]}, {"Citation": "Dibazar S. P., Fateh S., Daneshmandi S. (2015). Immunomodulatory effects of clove (syzygium aromaticum) constituents on macrophages: In vitro evaluations of aqueous and ethanolic components. J. Immunotoxicol. 12, 124\u2013131. 10.3109/1547691X.2014.912698", "ArticleIdList": ["10.3109/1547691X.2014.912698", "24873744"]}, {"Citation": "Dinda A., Gitman M., Singhal P. C. (2005). Immunomodulatory effect of morphine: Therapeutic implications. Expert Opin. drug Saf. 4, 669\u2013675. 10.1517/14740338.4.4.669", "ArticleIdList": ["10.1517/14740338.4.4.669", "16011446"]}, {"Citation": "Djaldetti M., Bessler H. (2017). Nicotine modifies cytokine production by human mononuclears stimulated by colon cancer cells. Colorectal Canc 3."}, {"Citation": "Dorri M., Hashemitabar S., Hosseinzadeh H. (2018). Cinnamon (cinnamomum zeylanicum) as an antidote or a protective agent against natural or chemical toxicities: A review. Drug Chem. Toxicol. 41, 338\u2013351. 10.1080/01480545.2017.1417995", "ArticleIdList": ["10.1080/01480545.2017.1417995", "29319361"]}, {"Citation": "Dzoyem J., Mcgaw L., Kuete V., Bakowsky U. (2017). Anti-inflammatory and anti-nociceptive activities of African medicinal spices and vegetables. Medicinal spices and vegetables from Africa . Elsevier."}, {"Citation": "Edalatifard M., Akhtari M., Salehi M., Naderi Z., Jamshidi A., Mostafaei S., et al. (2020). Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: Results from a randomised controlled clinical trial. Eur. Respir. J. 56, 2002808. 10.1183/13993003.02808-2020", "ArticleIdList": ["10.1183/13993003.02808-2020", "PMC7758541", "32943404"]}, {"Citation": "el-Gengaihi S. E., Aboul-Enein A. M., Mohammed M. A. (2020a). Antiproliferative effect and chemical constituents of annona species. Plant Arch. 20, 2650\u20132657."}, {"Citation": "el-Gengaihi S. E., Hamed M. A., Khalaf-Allah A. E.-R. M., Mohammed M. A. (2013). Golden berry juice attenuates the severity of hepatorenal injury. J. Diet. Suppl. 10, 357\u2013369. 10.3109/19390211.2013.830675", "ArticleIdList": ["10.3109/19390211.2013.830675", "24168372"]}, {"Citation": "el-Gengaihi S. E., Mohammed M. A., Aboubaker D., Shoaib R. M., Asker M., Abdelhamid S., et al. (2020b). Chemical, biological, and molecular studies on different citrus species wastes. Plant Arch. 20, 2773\u20132782."}, {"Citation": "el-Saber Batiha G., Magdy Beshbishy A., G Wasef L., Elewa Y. H., A al-Sagan A., el-Hack A., et al. (2020). Chemical constituents and pharmacological activities of garlic (allium sativum L.): A review. Nutrients 12, 872. 10.3390/nu12030872", "ArticleIdList": ["10.3390/nu12030872", "PMC7146530", "32213941"]}, {"Citation": "Elfiky A. A. (2021). Natural products may interfere with SARS-CoV-2 attachment to the host cell. J. Biomol. Struct. Dyn. 39, 3194\u20133203. 10.1080/07391102.2020.1761881", "ArticleIdList": ["10.1080/07391102.2020.1761881", "PMC7212544", "32340551"]}, {"Citation": "Enmozhi S. K., Raja K., Sebastine I., Joseph J. (2021). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. J. Biomol. Struct. Dyn. 39, 3092\u20133098. 10.1080/07391102.2020.1760136", "ArticleIdList": ["10.1080/07391102.2020.1760136", "PMC7212536", "32329419"]}, {"Citation": "Esposito S., Tagliabue C., Bosis S., Principi N. (2011). Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood. Int. J. Antimicrob. agents 37, 472\u2013475. 10.1016/j.ijantimicag.2011.01.008", "ArticleIdList": ["10.1016/j.ijantimicag.2011.01.008", "21377335"]}, {"Citation": "Fehr A. R., Channappanavar R., Perlman S. (2017). Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus. Annu. Rev. Med. 68, 387\u2013399. 10.1146/annurev-med-051215-031152", "ArticleIdList": ["10.1146/annurev-med-051215-031152", "PMC5353356", "27576010"]}, {"Citation": "Fehr A. R., Perlman S. (2015). Coronaviruses: An overview of their replication and pathogenesis. Coronaviruses 1282, 1\u201323. 10.1007/978-1-4939-2438-7_1", "ArticleIdList": ["10.1007/978-1-4939-2438-7_1", "PMC4369385", "25720466"]}, {"Citation": "Fei L., Jifeng F., Tiantian W., Yi H., Linghui P. (2017). Glycyrrhizin ameliorate ischemia reperfusion lung injury through downregulate TLR2 signaling cascade in alveolar macrophages. Front. Pharmacol. 8, 389. 10.3389/fphar.2017.00389", "ArticleIdList": ["10.3389/fphar.2017.00389", "PMC5472719", "28670282"]}, {"Citation": "Fu Q., Cui Q., Yang Y., Zhao X., Song X., Wang G., et al. (2018). Effect of resveratrol dry suspension on immune function of piglets. Evidence-Based Complementary Altern. Med. 2018, 1, 10. 10.1155/2018/5952707", "ArticleIdList": ["10.1155/2018/5952707"]}, {"Citation": "Fukada T., Kato H., Ozaki M., Yagi J. (2016). Impact of the timing of morphine administration on lipopolysaccharide-mediated lethal endotoxic shock in mice. Shock Inj. Inflamm. Sepsis Laboratory Clin. Approaches 45, 564\u2013569. 10.1097/SHK.0000000000000541", "ArticleIdList": ["10.1097/SHK.0000000000000541", "26682949"]}, {"Citation": "Fukada T., Nakayama R., Iwakiri H., Kato H., Yagi J., Ozaki M. (2012). Opioids inhibit lipopolysaccharide-mediated lethal shock in mice."}, {"Citation": "Gao X., Xu Y. X., Janakiraman N., Chapman R. A., Gautam S. C. (2001). Immunomodulatory activity of resveratrol: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharmacol. 62, 1299\u20131308. 10.1016/s0006-2952(01)00775-4", "ArticleIdList": ["10.1016/s0006-2952(01)00775-4", "11705464"]}, {"Citation": "Gautam S., Gautam A., Chhetri S., Bhattarai U. (2020). Immunity against COVID-19: Potential role of ayush kwath. J. Ayurveda Integr. Med. 13, 100350. 10.1016/j.jaim.2020.08.003", "ArticleIdList": ["10.1016/j.jaim.2020.08.003", "PMC7430223", "32837101"]}, {"Citation": "Gevers S., Kwa M., Wijnans E., van Nieuwkoop C. (2020). Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Clin. Microbiol. Infect. 26, 1276\u20131277. 10.1016/j.cmi.2020.05.006", "ArticleIdList": ["10.1016/j.cmi.2020.05.006", "PMC7228887", "32422406"]}, {"Citation": "G\u00f3MEZ-Pastora J., Weigand M., Kim J., Wu X., Strayer J., Palmer A. F., et al. (2020). Hyperferritinemia in critically ill COVID-19 patients\u2013is ferritin the product of inflammation or a pathogenic mediator? Clin. Chimica Acta; Int. J. Clin. Chem. 509, 249\u2013251. 10.1016/j.cca.2020.06.033", "ArticleIdList": ["10.1016/j.cca.2020.06.033", "PMC7306200", "32579952"]}, {"Citation": "Gonzalez-Rubio J., Navarro-Lopez C., Lopez-Najera E., Lopez-Najera A., Jimenez-Diaz L., Navarro-Lopez J. D., et al. (2020). Cytokine release syndrome (CRS) and nicotine in COVID-19 patients: Trying to calm the storm. Front. Immunol. 11, 1359. 10.3389/fimmu.2020.01359", "ArticleIdList": ["10.3389/fimmu.2020.01359", "PMC7300218", "32595653"]}, {"Citation": "Gordon A. C., Mouncey P. R., al-Beidh F., Rowan K. M., Nichol A. D., Arabi Y. M., et al. (2021). Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N. Engl. J. Med. 384, 1491\u20131502. 10.1056/NEJMoa2100433", "ArticleIdList": ["10.1056/NEJMoa2100433", "PMC7953461", "33631065"]}, {"Citation": "Gorgani L., Mohammadi M., Najafpour G. D., Nikzad M. (2017). Piperine\u2014the bioactive compound of black pepper: From isolation to medicinal formulations. Compr. Rev. Food Sci. Food Saf. 16, 124\u2013140. 10.1111/1541-4337.12246", "ArticleIdList": ["10.1111/1541-4337.12246", "33371546"]}, {"Citation": "Grupp S. A., Kalos M., Barrett D., Aplenc R., Porter D. L., Rheingold S. R., et al. (2013). Chimeric antigen receptor\u2013modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509\u20131518. 10.1056/NEJMoa1215134", "ArticleIdList": ["10.1056/NEJMoa1215134", "PMC4058440", "23527958"]}, {"Citation": "Guan W.-J., Liang W.-H., Zhao Y., Liang H.-R., Chen Z.-S., Li Y.-M., et al. (2020). Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur. Respir. J. 55, 2001227. 10.1183/13993003.01227-2020", "ArticleIdList": ["10.1183/13993003.01227-2020", "PMC7098485", "32217650"]}, {"Citation": "Gupta M., Kaur G. (2019). Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation. BMC complementary Altern. Med. 19, 217\u2013218. 10.1186/s12906-019-2635-0", "ArticleIdList": ["10.1186/s12906-019-2635-0", "PMC6694620", "31416451"]}, {"Citation": "Gupta S., Wang W., Hayek S. S., Chan L., Mathews K. S., Melamed M. L., et al. (2021). Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern. Med. 181, 41\u201351. 10.1001/jamainternmed.2020.6252", "ArticleIdList": ["10.1001/jamainternmed.2020.6252", "PMC7577201", "33080002"]}, {"Citation": "Hamed M. A., Mohammed M. A., Aboul Naser A. F., Matloub A. A., Fayed D. B., Ali S. A., et al. (2019). Optimization of curcuminoids extraction for evaluation against Parkinson\u2019s disease in rats. J. Biol. Act. Prod. Nat. 9, 335\u2013351. 10.1080/22311866.2019.1698317", "ArticleIdList": ["10.1080/22311866.2019.1698317"]}, {"Citation": "Haridas M., Sasidhar V., Nath P., Abhithaj J., Sabu A., Rammanohar P. (2021). Compounds of citrus medica and zingiber officinale for COVID-19 inhibition: In silico evidence for cues from Ayurveda. Future J. Pharm. Sci. 7, 13\u201319. 10.1186/s43094-020-00171-6", "ArticleIdList": ["10.1186/s43094-020-00171-6", "PMC7794642", "33457429"]}, {"Citation": "Hellou E., Mohsin J., Elemy A., Hakim F., Mustafa\u2010Hellou M., Hamoud S. (2022). Effect of ArtemiC in patients with COVID\u201019: A phase II prospective study. J. Cell. Mol. Med. 26, 3281\u20133289. 10.1111/jcmm.17337", "ArticleIdList": ["10.1111/jcmm.17337", "PMC9170814", "35587574"]}, {"Citation": "Hewlings S. J., Kalman D. S. (2017). Curcumin: A review of its effects on human health. Foods 6, 92. 10.3390/foods6100092", "ArticleIdList": ["10.3390/foods6100092", "PMC5664031", "29065496"]}, {"Citation": "Hirano T., Murakami M. (2020). COVID-19: A new virus, but a familiar receptor and cytokine release syndrome. Immunity 52, 731\u2013733. 10.1016/j.immuni.2020.04.003", "ArticleIdList": ["10.1016/j.immuni.2020.04.003", "PMC7175868", "32325025"]}, {"Citation": "Ho S.-C., Chang K.-S., Chang P.-W. (2013). Inhibition of neuroinflammation by cinnamon and its main components. Food Chem. 138, 2275\u20132282. 10.1016/j.foodchem.2012.12.020", "ArticleIdList": ["10.1016/j.foodchem.2012.12.020", "23497886"]}, {"Citation": "Horby P. W., Pessoa-Amorim G., Peto L., Brightling C. E., Sarkar R., Thomas K., et al. (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): Preliminary results of a randomised, controlled, open-label, platform trial. Medrxiv. 10.1101/2021.02.11.21249258", "ArticleIdList": ["10.1101/2021.02.11.21249258"]}, {"Citation": "Hosseini A., Hashemi V., Shomali N., Asghari F., Gharibi T., Akbari M., et al. (2020). Innate and adaptive immune responses against coronavirus. Biomedicine & Pharmacotherapy 132, 110859. 10.1016/j.biopha.2020.110859", "ArticleIdList": ["10.1016/j.biopha.2020.110859", "PMC7580677", "33120236"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. lancet 395, 497\u2013506. 10.1016/S0140-6736(20)30183-5", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Hui Q., Ammeter E., Liu S., Yang R., Lu P., Lahaye L., et al. (2020). Eugenol attenuates inflammatory response and enhances barrier function during lipopolysaccharide-induced inflammation in the porcine intestinal epithelial cells. J. Animal Sci. 98, skaa245. 10.1093/jas/skaa245", "ArticleIdList": ["10.1093/jas/skaa245", "PMC7531220", "32735667"]}, {"Citation": "Hwang Y.-C., Lu R.-M., Su S.-C., Chiang P.-Y., Ko S.-H., Ke F.-Y., et al. (2022). Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. J. Biomed. Sci. 29, 1\u201350. 10.1186/s12929-021-00784-w", "ArticleIdList": ["10.1186/s12929-021-00784-w", "PMC8724751", "34983527"]}, {"Citation": "Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., et al. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112\u2013116. 10.1038/nature03712", "ArticleIdList": ["10.1038/nature03712", "PMC7094998", "16001071"]}, {"Citation": "Jacobs J., Clark-Snustad K., Lee S. (2020). Case report of a SARS-CoV-2 infection in a patient with ulcerative colitis on tofacitinib. Inflamm. bowel Dis. 26, e64. 10.1093/ibd/izaa093", "ArticleIdList": ["10.1093/ibd/izaa093", "PMC7197538", "32342098"]}, {"Citation": "Jayakumar T., Hsieh C. Y., Lee J. J., Sheu J. R. (2013). Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evidence-Based Complementary and Alternative Medicine, 2013. 10.1155/2013/846740", "ArticleIdList": ["10.1155/2013/846740"]}, {"Citation": "Ji J., Zhang J., Shao Z., Xie Q., Zhong L., Liu Z. (2020). Glucocorticoid therapy does not delay viral clearance in COVID-19 patients. Crit. Care 24 (565), 1\u20134. 10.1186/s13054-020-03287-6", "ArticleIdList": ["10.1186/s13054-020-03287-6", "PMC7503440", "32958060"]}, {"Citation": "Kang O.-H., Choi J.-G., Lee J.-H., Kwon D.-Y. (2010). Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells. Molecules 15, 385\u2013398. 10.3390/molecules15010385", "ArticleIdList": ["10.3390/molecules15010385", "PMC6257122", "20110898"]}, {"Citation": "Kao T.-K., Ou Y.-C., Lin S.-Y., Pan H.-C., Song P.-J., Raung S.-L., et al. (2011). Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. J. Nutr. Biochem. 22, 612\u2013624. 10.1016/j.jnutbio.2010.01.011", "ArticleIdList": ["10.1016/j.jnutbio.2010.01.011", "21036586"]}, {"Citation": "Kashyap V. K., Dhasmana A., Yallapu M. M., Chauhan S. C., Jaggi M. (2020). Withania somnifera as a potential future drug molecule for COVID-19. Future Sci.", "ArticleIdList": ["PMC7702281", "33269342"]}, {"Citation": "Kato K., Yamashita S., Kitanaka S., Toyoshima S. (2001). Effect of gallic acid derivatives on secretion of Th1 cytokines and Th2 cytokines from anti CD3-stimulated spleen cells. Yakugaku zasshi J. Pharm. Soc. Jpn. 121, 451\u2013457. 10.1248/yakushi.121.451", "ArticleIdList": ["10.1248/yakushi.121.451", "11433779"]}, {"Citation": "Kaur G., Singh N., Samuel S. S., Bora H. K., Sharma S., Pachauri S. D., et al. (2015). Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension. Pharm. Biol. 53, 147\u2013157. 10.3109/13880209.2014.912240", "ArticleIdList": ["10.3109/13880209.2014.912240", "25237891"]}, {"Citation": "Khalaf-Allah A. E.-R. M., el-Gengaihi S. E., Hamed M. A., Zahran H. G., Mohammed M. A. (2016). Chemical composition of golden berry leaves against hepato-renal fibrosis. J. Diet. Suppl. 13, 378\u2013392. 10.3109/19390211.2015.1099584", "ArticleIdList": ["10.3109/19390211.2015.1099584", "26634867"]}, {"Citation": "Khalil A. A., Rahman U., Khan M. R., Sahar A., Mehmood T., Khan M. (2017). Essential oil eugenol: Sources, extraction techniques and nutraceutical perspectives. RSC Adv. 7, 32669\u201332681. 10.1039/c7ra04803c", "ArticleIdList": ["10.1039/c7ra04803c"]}, {"Citation": "Khan F. R., Kazmi S. M. R., Iqbal N. T., Iqbal J., Ali S. T., Abbas S. A. (2020). A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial. Trials 21, 1\u20134. 10.1186/s13063-020-04634-2", "ArticleIdList": ["10.1186/s13063-020-04634-2", "PMC7487448", "32928313"]}, {"Citation": "Kim G. D., Lee S. E., Kim T. H., Jin Y. H., Park Y. S., Park C. S. (2012). Melatonin suppresses acrolein\u2010induced IL\u20108 production in human pulmonary fibroblasts. J. pineal Res. 52, 356\u2013364. 10.1111/j.1600-079X.2011.00950.x", "ArticleIdList": ["10.1111/j.1600-079X.2011.00950.x", "21951103"]}, {"Citation": "Kim S.-H., Jun C.-D., Suk K., Choi B.-J., Lim H., Park S., et al. (2006). Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 91, 123\u2013131. 10.1093/toxsci/kfj063", "ArticleIdList": ["10.1093/toxsci/kfj063", "16322071"]}, {"Citation": "Kim S. H., Lee Y. C. (2009). Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin\u2010induced asthma model. J. Pharm. Pharmacol. 61, 353\u2013359. 10.1211/jpp/61.03.0010", "ArticleIdList": ["10.1211/jpp/61.03.0010", "19222908"]}, {"Citation": "Klinkhammer J., Schnepf D., Ye L., Schwaderlapp M., Gad H. H., Hartmann R., et al. (2018). IFN-\u03bb prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. elife 7, e33354. 10.7554/eLife.33354", "ArticleIdList": ["10.7554/eLife.33354", "PMC5953542", "29651984"]}, {"Citation": "Knoll M. D., Wonodi C. (2021). Oxford\u2013AstraZeneca COVID-19 vaccine efficacy. Lancet 397, 72\u201374. 10.1016/S0140-6736(20)32623-4", "ArticleIdList": ["10.1016/S0140-6736(20)32623-4", "PMC7832220", "33306990"]}, {"Citation": "Kong D., Wang Z., Tian J., Liu T., Zhou H. (2019). Glycyrrhizin inactivates toll\u2010like receptor (TLR) signaling pathway to reduce lipopolysaccharide\u2010induced acute lung injury by inhibiting TLR2. J. Cell. physiology 234, 4597\u20134607. 10.1002/jcp.27242", "ArticleIdList": ["10.1002/jcp.27242", "30203548"]}, {"Citation": "Koshak A. E., Koshak E. A., Mobeireek A. F., Badawi M. A., Wali S. O., Malibary H. M., et al. (2021). Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial. Complementary Ther. Med. 61, 102769. 10.1016/j.ctim.2021.102769", "ArticleIdList": ["10.1016/j.ctim.2021.102769", "PMC8364675", "34407441"]}, {"Citation": "Krischuns T., Gunl F., Henschel L., Binder M., Willemsen J., Schloer S., et al. (2018). Phosphorylation of TRIM28 enhances the expression of IFN-\u03b2 and proinflammatory cytokines during HPAIV infection of human lung epithelial cells. Front. Immunol. 9, 2229. 10.3389/fimmu.2018.02229", "ArticleIdList": ["10.3389/fimmu.2018.02229", "PMC6172303", "30323812"]}, {"Citation": "Kumar A., Prasad G., Srivastav S., Gautam V. K., Sharma N. (2020). Efficacy and safety of guduchi ghan vati in the management of asymptomatic COVID-19 infection: An open label feasibility study. MedRxiv, 2020\u201309."}, {"Citation": "Kurose K., Yatagai M. (2005). Components of the essential oils of Azadirachta indica A. Juss, Azadirachta siamensis Velton, and Azadirachta excelsa (Jack) Jacobs and their comparison. J. Wood Sci. 51, 185\u2013188. 10.1007/s10086-004-0640-4", "ArticleIdList": ["10.1007/s10086-004-0640-4"]}, {"Citation": "Lang A., Lahav M., Sakhnini E., Barshack I., Fidder H. H., Avidan B., et al. (2004). Allicin inhibits spontaneous and TNF-\u03b1 induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells. Clin. Nutr. 23, 1199\u20131208. 10.1016/j.clnu.2004.03.011", "ArticleIdList": ["10.1016/j.clnu.2004.03.011", "15380914"]}, {"Citation": "Lee D. W., Gardner R., Porter D. L., Louis C. U., Ahmed N., Jensen M., et al. (2014). Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124 (2), 188\u2013195.", "ArticleIdList": ["PMC4093680", "24876563"]}, {"Citation": "Lee W., Lee S. Y., Son Y.-J., Yun J.-M. (2015). Gallic acid decreases inflammatory cytokine secretion through histone acetyltransferase/histone deacetylase regulation in high glucose-induced human monocytes. J. Med. food 18, 793\u2013801. 10.1089/jmf.2014.3342", "ArticleIdList": ["10.1089/jmf.2014.3342", "25807193"]}, {"Citation": "Leng Z., Zhu R., Hou W., Feng Y., Yang Y., Han Q., et al. (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 11, 216\u2013228. 10.14336/AD.2020.0228", "ArticleIdList": ["10.14336/AD.2020.0228", "PMC7069465", "32257537"]}, {"Citation": "Lescure F.-X., Honda H., Fowler R. A., Lazar J. S., Shi G., Wung P., et al. (2021). Sarilumab in patients admitted to hospital with severe or critical COVID-19: A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir. Med. 9, 522\u2013532. 10.1016/S2213-2600(21)00099-0", "ArticleIdList": ["10.1016/S2213-2600(21)00099-0", "PMC8078879", "33676590"]}, {"Citation": "Li Y., He S., Tang J., Ding N., Chu X., Cheng L., et al. (2017). Andrographolide inhibits inflammatory cytokines secretion in LPS-stimulated RAW264. 7 cells through suppression of NF-\u03baB/MAPK signaling pathway. Evidence-based Complementary Altern. Med., 2017, 1, 9. 10.1155/2017/8248142", "ArticleIdList": ["10.1155/2017/8248142", "PMC5476883", "28676833"]}, {"Citation": "Li Y., Yao J., Han C., Yang J., Chaudhry M., Wang S., et al. (2016). Quercetin, inflammation and immunity. Nutrients 8, 167. 10.3390/nu8030167", "ArticleIdList": ["10.3390/nu8030167", "PMC4808895", "26999194"]}, {"Citation": "Liang W., Guan W., Chen R., Wang W., Li J., Xu K., et al. (2020). Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. lancet Oncol. 21, 335\u2013337. 10.1016/S1470-2045(20)30096-6", "ArticleIdList": ["10.1016/S1470-2045(20)30096-6", "PMC7159000", "32066541"]}, {"Citation": "Liang Y.-D., Bai W.-J., Li C.-G., Xu L.-H., Wei H.-X., Pan H., et al. (2016). Piperine suppresses pyroptosis and interleukin-1\u03b2 release upon ATP triggering and bacterial infection. Front. Pharmacol. 7, 390. 10.3389/fphar.2016.00390", "ArticleIdList": ["10.3389/fphar.2016.00390", "PMC5071324", "27812336"]}, {"Citation": "Lin Y., Shi R., Wang X., Shen H.-M. (2008). Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. cancer drug targets 8, 634\u2013646. 10.2174/156800908786241050", "ArticleIdList": ["10.2174/156800908786241050", "PMC2615542", "18991571"]}, {"Citation": "Liu J., Bodnar B. H., Meng F., Khan A. I., Wang X., Saribas S., et al. (2021). Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor. Cell. & Biosci. 11 (1), 1\u201315. 10.1186/s13578-021-00680-8", "ArticleIdList": ["10.1186/s13578-021-00680-8", "PMC8404181", "34461999"]}, {"Citation": "Liu J., Zheng X., Tong Q., Li W., Wang B., Sutter K., et al. (2020a). Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS\u2010CoV, MERS\u2010CoV, and 2019\u2010nCoV. J. Med. virology 92, 491\u2013494. 10.1002/jmv.25709", "ArticleIdList": ["10.1002/jmv.25709", "PMC7166760", "32056249"]}, {"Citation": "Liu M.-Y., Zheng B., Zhang Y., Li J.-P. (2020b). Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019. Chronic Dis. Transl. Med. 6, 98\u2013105. 10.1016/j.cdtm.2020.05.003", "ArticleIdList": ["10.1016/j.cdtm.2020.05.003", "PMC7236734", "32550040"]}, {"Citation": "Liu Q., Zhou Y.-H., Yang Z.-Q. (2016). The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell. Mol. Immunol. 13, 3\u201310. 10.1038/cmi.2015.74", "ArticleIdList": ["10.1038/cmi.2015.74", "PMC4711683", "26189369"]}, {"Citation": "Liu Z., Ying Y. (2020). The inhibitory effect of curcumin on virus-induced cytokine storm and its potential use in the associated severe pneumonia. Front. Cell. Dev. Biol. 8, 479. 10.3389/fcell.2020.00479", "ArticleIdList": ["10.3389/fcell.2020.00479", "PMC7303286", "32596244"]}, {"Citation": "Lodhi S., Vadnere G. P., Patil K. D., Patil T. P. (2020). Protective effects of luteolin on injury induced inflammation through reduction of tissue uric acid and pro-inflammatory cytokines in rats. J. traditional complementary Med. 10, 60\u201369. 10.1016/j.jtcme.2019.02.004", "ArticleIdList": ["10.1016/j.jtcme.2019.02.004", "PMC6957812", "31956559"]}, {"Citation": "Lu J., Ma Y., Wu J., Huang H., Wang X., Chen Z., et al. (2019). A review for the neuroprotective effects of andrographolide in the central nervous system. Biomed. Pharmacother. 117, 109078. 10.1016/j.biopha.2019.109078", "ArticleIdList": ["10.1016/j.biopha.2019.109078", "31181444"]}, {"Citation": "Ma J., Xia P., Zhou Y., Liu Z., Zhou X., Wang J., et al. (2020). Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19, 214. Orlando, Fla: Clinical Immunology, 108408.", "ArticleIdList": ["PMC7118642", "32247038"]}, {"Citation": "Madera-Salcedo I. K., Cruz S. L., Gonzalez-Espinosa C. (2011). Morphine decreases early peritoneal innate immunity responses in Swiss\u2013Webster and C57BL6/J mice through the inhibition of mast cell TNF-\u03b1 release. J. Neuroimmunol. 232, 101\u2013107. 10.1016/j.jneuroim.2010.10.017", "ArticleIdList": ["10.1016/j.jneuroim.2010.10.017", "21087796"]}, {"Citation": "Mahallawi W. H., Khabour O. F., Zhang Q., Makhdoum H. M., Suliman B. A. (2018). MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 104, 8\u201313. 10.1016/j.cyto.2018.01.025", "ArticleIdList": ["10.1016/j.cyto.2018.01.025", "PMC7129230", "29414327"]}, {"Citation": "Malaguarnera L. (2019). Influence of resveratrol on the immune response. Nutrients 11, 946. 10.3390/nu11050946", "ArticleIdList": ["10.3390/nu11050946", "PMC6566902", "31035454"]}, {"Citation": "Mandlik D. S., Namdeo A. G. (2021). Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. J. Diet. Suppl. 18, 183\u2013226. 10.1080/19390211.2020.1741484", "ArticleIdList": ["10.1080/19390211.2020.1741484", "32242751"]}, {"Citation": "Marinella M. A. (2020). Indomethacin and resveratrol as potential treatment adjuncts for SARS\u2010CoV\u20102/COVID\u201019. Int. J. Clin. Pract. 74, e13535. 10.1111/ijcp.13535", "ArticleIdList": ["10.1111/ijcp.13535", "PMC7261995", "32412158"]}, {"Citation": "Masi\u00e1 M., Fern\u00e1NDEZ-Gonz\u00e1LEZ M., Padilla S., Ortega P., Garc\u00edA J. A., Agull\u00f3 V., et al. (2020). Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study. EBioMedicine 60, 102999. 10.1016/j.ebiom.2020.102999", "ArticleIdList": ["10.1016/j.ebiom.2020.102999", "PMC7492814", "32950003"]}, {"Citation": "Maurya S. P., Das B. K., Singh R., Tyagi S. (2019). Effect of Withania somnifer on CD38 expression on CD8+ T lymphocytes among patients of HIV infection. Clin. Immunol. 203, 122\u2013124. 10.1016/j.clim.2019.04.003", "ArticleIdList": ["10.1016/j.clim.2019.04.003", "31004791"]}, {"Citation": "Maurya V. K., Kumar S., Prasad A. K., Bhatt M. L., Saxena S. K. (2020). Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virusdisease 31, 179\u2013193. 10.1007/s13337-020-00598-8", "ArticleIdList": ["10.1007/s13337-020-00598-8", "PMC7245990", "32656311"]}, {"Citation": "Mehrbod P., Abdalla M. A., Fotouhi F., Heidarzadeh M., Aro A. O., Eloff J. N., et al. (2018). Immunomodulatory properties of quercetin-3-O-\u03b1-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus. BMC complementary Altern. Med. 18 (1), 1\u201310. 10.1186/s12906-018-2246-1", "ArticleIdList": ["10.1186/s12906-018-2246-1", "PMC6003079", "29903008"]}, {"Citation": "Meng W., Xiaoliang R., Xiumei G., Vincieri F. F., Bilia A. R. (2009). Stability of active ingredients of traditional Chinese medicine (TCM). Nat. Product. Commun. 4, 1934578X0900401\u20131776. 10.1177/1934578x0900401229", "ArticleIdList": ["10.1177/1934578x0900401229", "20120121"]}, {"Citation": "Min K. J., Jang J. H., Kwon T. K. (2012). Inhibitory effects of melatonin on the lipopolysaccharide\u2010induced CC chemokine expression in BV2 murine microglial cells are mediated by suppression of Akt\u2010induced NF\u2010\u03baB and STAT/GAS activity. J. pineal Res. 52, 296\u2013304. 10.1111/j.1600-079X.2011.00943.x", "ArticleIdList": ["10.1111/j.1600-079X.2011.00943.x", "22225513"]}, {"Citation": "Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., et al. (2023). Long covid outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. bmj, 380.", "ArticleIdList": ["PMC9832503", "36631153"]}, {"Citation": "Modi B., Hernandez-Henderson M., Yang D., Klein J., Dadwal S., Kopp E., et al. (2019). Ruxolitinib as salvage therapy for chronic graft-versus-host disease. Biol. Blood Marrow Transplant. 25, 265\u2013269. 10.1016/j.bbmt.2018.09.003", "ArticleIdList": ["10.1016/j.bbmt.2018.09.003", "30201397"]}, {"Citation": "Mohammed M. A., Elgammal E. W., Gaara A. H., el Raey M. A. (2022a). Synergistic effect of Silver and ZnO nanoparticles green synthesized by Vitis vinifera stem extract with Ampicillin against some pathogenic microbes. Egypt. J. Chem. 65, 1\u20132."}, {"Citation": "Mohammed M. A., Hamed M. A., el-Gengaihi S. E., Enein A. M. A., Kachlicki P., Hassan E. M. (2022b). Profiling of secondary metabolites and DNA typing of three different Annona cultivars grown in Egypt. Metabolomics 18, 49\u201321. 10.1007/s11306-022-01911-w", "ArticleIdList": ["10.1007/s11306-022-01911-w", "PMC9252975", "35781851"]}, {"Citation": "Mohammed M. A., Ibrahim B. M., Abdel-Latif Y., Hassan A. H., el Raey M. A., Hassan E. M., et al. (2022c). Pharmacological and metabolomic profiles of Musa acuminata wastes as a new potential source of anti-ulcerative colitis agents. Sci. Rep. 12 (1), 10595. 10.1038/s41598-022-14599-8", "ArticleIdList": ["10.1038/s41598-022-14599-8", "PMC9218116", "35732649"]}, {"Citation": "Moll G., Drzeniek N., Kamhieh-Milz J., Geissler S., Volk H.-D., Reinke P. (2020). MSC therapies for COVID-19: Importance of patient coagulopathy, thromboprophylaxis, cell product quality and mode of delivery for treatment safety and efficacy. Front. Immunol. 11, 1091. 10.3389/fimmu.2020.01091", "ArticleIdList": ["10.3389/fimmu.2020.01091", "PMC7249852", "32574263"]}, {"Citation": "Montesarchio V., Parrella R., Iommelli C., Bianco A., Manzillo E., Fraganza F., et al. (2020). Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J. Immunother. cancer 8, e001089. 10.1136/jitc-2020-001089", "ArticleIdList": ["10.1136/jitc-2020-001089", "PMC7418768", "32784217"]}, {"Citation": "Morassi M., Bagatto D., Cobelli M., D\u2019Agostini S., Gigli G. L., Bna C., et al. (2020). Stroke in patients with SARS-CoV-2 infection: Case series. J. neurology 267, 2185\u20132192. 10.1007/s00415-020-09885-2", "ArticleIdList": ["10.1007/s00415-020-09885-2", "PMC7238403", "32436105"]}, {"Citation": "Murakami M., Kamimura D., Hirano T. (2019). Pleiotropy and specificity: Insights from the interleukin 6 family of cytokines. Immunity 50, 812\u2013831. 10.1016/j.immuni.2019.03.027", "ArticleIdList": ["10.1016/j.immuni.2019.03.027", "30995501"]}, {"Citation": "Murck H. (2020). Symptomatic protective action of glycyrrhizin (licorice) in COVID-19 infection? Front. Immunol. 11, 1239. 10.3389/fimmu.2020.01239", "ArticleIdList": ["10.3389/fimmu.2020.01239", "PMC7270278", "32574273"]}, {"Citation": "National Academies Of Sciences E. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research.", "ArticleIdList": ["28182367"]}, {"Citation": "Nawaz M. A., Huang Y., Bie Z., Ahmed W., Reiter R. J., Niu M., et al. (2016). Corrigendum: Melatonin: Current status and future perspectives in plant science. Front. plant Sci. 7, 714. 10.3389/fpls.2016.00714", "ArticleIdList": ["10.3389/fpls.2016.00714", "PMC4878255", "27252727"]}, {"Citation": "Nelson B. C., Laracy J., Shoucri S., Dietz D., Zucker J., Patel N., et al. (2021). Clinical outcomes associated with methylprednisolone in mechanically ventilated patients with COVID-19. Clin. Infect. Dis. 72, e367\u2013e372. 10.1093/cid/ciaa1163", "ArticleIdList": ["10.1093/cid/ciaa1163", "PMC7454332", "32772069"]}, {"Citation": "Nie X., Chen S.-R., Wang K., Peng Y., Wang Y. T., Wang D., et al. (2017). Attenuation of innate immunity by andrographolide derivatives through NF-\u03baB signaling pathway. Sci. Rep. 7 (1), 4738. 10.1038/s41598-017-04673-x", "ArticleIdList": ["10.1038/s41598-017-04673-x", "PMC5498490", "28680097"]}, {"Citation": "Orleans L., Is Vice H., Manchikanti L. (2020). Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: The case for compassionate use. Pain physician 23, E71\u2013E83. 10.36076/ppj.2020/23/e71", "ArticleIdList": ["10.36076/ppj.2020/23/e71", "32214286"]}, {"Citation": "Ortega-Pe\u00f1A M., Gonz\u00e1LEZ-Cuevas R. (2021). Familiar dermatologic drugs as therapies for COVID-19. Actas Dermo-Sifiliogr\u00e1ficas Engl. Ed. 112, 118\u2013126. 10.1016/j.ad.2020.09.004", "ArticleIdList": ["10.1016/j.ad.2020.09.004", "PMC7546972", "33045209"]}, {"Citation": "Pandit M., Latha N. (2020). In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection."}, {"Citation": "Peacocke E. F., Heupink L. F., Fr\u00f8NSDAL K., Dahl E. H., Chola L. (2021). Global access to COVID-19 vaccines: A scoping review of factors that may influence equitable access for low and middle-income countries. BMJ open 11, e049505. 10.1136/bmjopen-2021-049505", "ArticleIdList": ["10.1136/bmjopen-2021-049505", "PMC8487019", "34593496"]}, {"Citation": "Peter A. E., Sandeep B., Rao B. G., Kalpana V. L. (2021). Calming the storm: Natural immunosuppressants as adjuvants to target the cytokine storm in COVID-19. Front. Pharmacol. 11, 583777. 10.3389/fphar.2020.583777", "ArticleIdList": ["10.3389/fphar.2020.583777", "PMC7941276", "33708109"]}, {"Citation": "Peterson D., Damsky W., King B. (2020). The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J. Am. Acad. Dermatology 82, e223\u2013e226. 10.1016/j.jaad.2020.03.099", "ArticleIdList": ["10.1016/j.jaad.2020.03.099", "PMC7144601", "32278797"]}, {"Citation": "Piantoni S., Patroni A., Toniati P., Furloni R., Franceschini F., Andreoli L., et al. (2020). Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease. Rheumatology 59, 1769\u20131770. 10.1093/rheumatology/keaa217", "ArticleIdList": ["10.1093/rheumatology/keaa217", "PMC7313780", "32472681"]}, {"Citation": "Piao W.-H., Campagnolo D., Dayao C., Lukas R. J., Wu J., Shi F.-D. (2009). Nicotine and inflammatory neurological disorders. Acta Pharmacol. Sin. 30, 715\u2013722. 10.1038/aps.2009.67", "ArticleIdList": ["10.1038/aps.2009.67", "PMC4002379", "19448649"]}, {"Citation": "Plat J., van Brakel L., Mensink R. P. (2022). Plant stanol esters might optimise the immune response and improve the SARS-CoV-2/COVID-19 vaccine efficacy in overweight and obese subjects. Br. J. Nutr. 127, 1117\u20131118. 10.1017/S0007114521001781", "ArticleIdList": ["10.1017/S0007114521001781", "PMC8367865", "34044900"]}, {"Citation": "Pramod K., Ansari S. H., Ali J. (2010). Eugenol: A natural compound with versatile pharmacological actions. Nat. Product. Commun. 5, 1934578X1000501\u20132006. 10.1177/1934578x1000501236", "ArticleIdList": ["10.1177/1934578x1000501236", "21299140"]}, {"Citation": "Prasanth D., Murahari M., Chandramohan V., Panda S. P., Atmakuri L. R., Guntupalli C. (2020). In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J. Biomol. Struct. Dyn. 39, 4618\u20134632. 10.1080/07391102.2020.1779129", "ArticleIdList": ["10.1080/07391102.2020.1779129", "PMC7332870", "32567989"]}, {"Citation": "Rabaan A. A., al-Ahmed S. H., Muhammad J., Khan A., Sule A. A., Tirupathi R., et al. (2021). Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines 9, 436. 10.3390/vaccines9050436", "ArticleIdList": ["10.3390/vaccines9050436", "PMC8145892", "33946736"]}, {"Citation": "Rahardjo B., Widjajanto E., Sujuti H., Keman K. (2014). Curcumin decreased level of proinflammatory cytokines in monocyte cultures exposed to preeclamptic plasma by affecting the transcription factors NF-\u03baB and PPAR-\u03b3. Biomarkers Genomic Med. 6, 105\u2013115. 10.1016/j.bgm.2014.06.002", "ArticleIdList": ["10.1016/j.bgm.2014.06.002"]}, {"Citation": "Rahmati M., Moosavi M. A. (2020). Cytokine-targeted therapy in severely ill COVID-19 patients: Options and cautions. mortality, 105954."}, {"Citation": "Reiter R. J., Sharma R., Ma Q., Dominquez-Rodriguez A., Marik P. E., Abreu-Gonzalez P. (2020). Melatonin inhibits COVID-19-induced cytokine storm by reversing aerobic glycolysis in immune cells: A mechanistic analysis. Med. drug Discov. 6, 100044. 10.1016/j.medidd.2020.100044", "ArticleIdList": ["10.1016/j.medidd.2020.100044", "PMC7211589", "32395713"]}, {"Citation": "Rhimi W., Mohammed M. A., Zarea A. A. K., Greco G., Tempesta M., Otranto D., et al. (2022). Antifungal, antioxidant and antibiofilm activities of essential oils of Cymbopogon spp. Antibiotics 11, 829. 10.3390/antibiotics11060829", "ArticleIdList": ["10.3390/antibiotics11060829", "PMC9220269", "35740234"]}, {"Citation": "Ribeiro D., Freitas M., Tome S. M., Silva A. M., Laufer S., Lima J. L., et al. (2015). Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood. Inflammation 38, 858\u2013870. 10.1007/s10753-014-9995-x", "ArticleIdList": ["10.1007/s10753-014-9995-x", "25139581"]}, {"Citation": "Rieder S. A., Nagarkatti P., Nagarkatti M. (2012). Multiple anti\u2010inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B\u2010induced lung injury. Br. J. Pharmacol. 167, 1244\u20131258. 10.1111/j.1476-5381.2012.02063.x", "ArticleIdList": ["10.1111/j.1476-5381.2012.02063.x", "PMC3504991", "22646800"]}, {"Citation": "Rolta R., Salaria D., Sharma B., Awofisayo O., Fadare O. A., Sharma S., et al. (2022). Methylxanthines as potential inhibitor of SARS-CoV-2: An in silico approach. Curr. Pharmacol. Rep. 8, 149\u2013170. 10.1007/s40495-021-00276-3", "ArticleIdList": ["10.1007/s40495-021-00276-3", "PMC8901432", "35281252"]}, {"Citation": "Rolta R., Salaria D., Sharma P., Sharma B., Kumar V., Rathi B., et al. (2021a). Phytocompounds of rheum emodi, thymus serpyllum, and artemisia annua inhibit spike protein of SARS-CoV-2 binding to ACE2 receptor: In silico approach. Curr. Pharmacol. Rep. 7, 135\u2013149. 10.1007/s40495-021-00259-4", "ArticleIdList": ["10.1007/s40495-021-00259-4", "PMC8279807", "34306988"]}, {"Citation": "Rolta R., Yadav R., Salaria D., Trivedi S., Imran M., Sourirajan A., et al. (2021b). In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: An approach to prevent virus assembly. J. Biomol. Struct. Dyn. 39, 7017\u20137034. 10.1080/07391102.2020.1804457", "ArticleIdList": ["10.1080/07391102.2020.1804457", "PMC7484575", "32851912"]}, {"Citation": "Rosas I. O., Br\u00e4U N., Waters M., Go R. C., Hunter B. D., Bhagani S., et al. (2021). Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N. Engl. J. Med. 384, 1503\u20131516. 10.1056/NEJMoa2028700", "ArticleIdList": ["10.1056/NEJMoa2028700", "PMC7953459", "33631066"]}, {"Citation": "Roumier M., Paule R., Matthieu G., Vallee A., Ackermann F. (2020). Interleukin-6 blockade for severe COVID-19. medrxiv ."}, {"Citation": "Sagar V., Kumar A. H. (2020). Efficacy of natural compounds from Tinospora cordifolia against SARS-CoV-2 protease, surface glycoprotein and RNA polymerase. Virology, 1\u201310."}, {"Citation": "Saha P., Katarkar A., Das B., Bhattacharyya A., Chaudhuri K. (2016). 6-gingerol inhibits Vibrio cholerae-induced proinflammatory cytokines in intestinal epithelial cells via modulation of NF-\u03baB. Pharm. Biol. 54, 1606\u20131615. 10.3109/13880209.2015.1110598", "ArticleIdList": ["10.3109/13880209.2015.1110598", "26987371"]}, {"Citation": "Sajjadi S., Mehregan I., Taheri M. (2015). Essential oil composition of Hypericum triquetrifolium Turra growing wild in Iran. Res. Pharm. Sci. 10, 90\u201394.", "ArticleIdList": ["PMC4578217", "26430462"]}, {"Citation": "Salehi B., Sharopov F., Fokou P. V. T., Kobylinska A., Jonge L. D., Tadio K., et al. (2019). Melatonin in medicinal and food plants: Occurrence, bioavailability, and health potential for humans. Cells 8, 681. 10.3390/cells8070681", "ArticleIdList": ["10.3390/cells8070681", "PMC6678868", "31284489"]}, {"Citation": "Sannegowda K., Venkatesha S., Moudgil K. (2015). Tinospora cordifolia inhibits autoimmune arthritis by regulating key immune mediators of inflammation and bone damage. Int. J. Immunopathol. Pharmacol. 28, 521\u2013531. 10.1177/0394632015608248", "ArticleIdList": ["10.1177/0394632015608248", "PMC8082752", "26467057"]}, {"Citation": "Sasidharan S., Sarkar N., Saudagar P. (2022). Discovery of compounds inhibiting SARS-COV-2 multi-targets. J. Biomol. Struct. Dyn., 1\u201316. 10.1080/07391102.2021.2025149", "ArticleIdList": ["10.1080/07391102.2021.2025149", "34994297"]}, {"Citation": "Scarsi M., Piantoni S., Colombo E., Air\u00f3 P., Richini D., Miclini M., et al. (2020). Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome. Ann. rheumatic Dis. 79, 1286\u20131289. 10.1136/annrheumdis-2020-217712", "ArticleIdList": ["10.1136/annrheumdis-2020-217712", "PMC7509521", "32732245"]}, {"Citation": "Schink A., Naumoska K., Kitanovski Z., Kampf C. J., Fr\u00f6HLICH-Nowoisky J., Thines E., et al. (2018). Anti-inflammatory effects of cinnamon extract and identification of active compounds influencing the TLR2 and TLR4 signaling pathways. Food & Funct. 9, 5950\u20135964. 10.1039/c8fo01286e", "ArticleIdList": ["10.1039/c8fo01286e", "30379176"]}, {"Citation": "Seigneuric C., Camara B., Delmont J., Busato F., Payen J., Armengaud M., et al. (2008). Quinquina and man. Med. Trop. Rev. Corps Sante Colon. 68, 459\u2013462.", "ArticleIdList": ["19068974"]}, {"Citation": "Senthil Kumar K., Gokila Vani M., Wang C.-S., Chen C.-C., Chen Y.-C., Lu L.-P., et al. (2020). Geranium and lemon essential oils and their active compounds downregulate angiotensin-converting enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain, in epithelial cells. Plants 9, 770. 10.3390/plants9060770", "ArticleIdList": ["10.3390/plants9060770", "PMC7355681", "32575476"]}, {"Citation": "Shakoory B., Carcillo J. A., Chatham W. W., Amdur R. L., Zhao H., Dinarello C. A., et al. (2016). Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: Reanalysis of a prior phase III trial. Crit. care Med. 44, 275\u2013281. 10.1097/CCM.0000000000001402", "ArticleIdList": ["10.1097/CCM.0000000000001402", "PMC5378312", "26584195"]}, {"Citation": "Sharifi-Rad J., Cristina Cirone Silva N., Jantwal A., D Bhatt I., Sharopov F., C Cho W., et al. (2019). Therapeutic potential of allicin-rich garlic preparations: Emphasis on clinical evidence toward upcoming drugs formulation. Appl. Sci. 9, 5555. 10.3390/app9245555", "ArticleIdList": ["10.3390/app9245555"]}, {"Citation": "Sharifi-Rad M., Varoni E. M., Salehi B., Sharifi-Rad J., Matthews K. R., Ayatollahi S. A., et al. (2017). Plants of the genus Zingiber as a source of bioactive phytochemicals: From tradition to pharmacy. Molecules 22, 2145. 10.3390/molecules22122145", "ArticleIdList": ["10.3390/molecules22122145", "PMC6149881", "29207520"]}, {"Citation": "Sharma U., Bala M., Kumar N., Singh B., Munshi R. K., Bhalerao S. (2012). Immunomodulatory active compounds from Tinospora cordifolia. J. Ethnopharmacol. 141, 918\u2013926. 10.1016/j.jep.2012.03.027", "ArticleIdList": ["10.1016/j.jep.2012.03.027", "22472109"]}, {"Citation": "Sharma V., Kaushik S., Pandit P., Dhull D., Yadav J. P., Kaushik S. (2019). Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus. Appl. Microbiol. Biotechnol. 103, 881\u2013891. 10.1007/s00253-018-9488-1", "ArticleIdList": ["10.1007/s00253-018-9488-1", "30413849"]}, {"Citation": "Sheng Y., Wu T., Dai Y., Ji K., Zhong Y., Xue Y. (2020). The effect of 6-gingerol on inflammatory response and Th17/Treg balance in DSS-induced ulcerative colitis mice. Ann. Transl. Med. 8, 442. 10.21037/atm.2020.03.141", "ArticleIdList": ["10.21037/atm.2020.03.141", "PMC7210157", "32395486"]}, {"Citation": "Shimabukuro-Vornhagen A., G\u00f6DEL P., Subklewe M., Stemmler H. J., Schl\u00f6\u00dfER H. A., Schlaak M., et al. (2018). Cytokine release syndrome. J. Immunother. cancer 6, 56\u201314. 10.1186/s40425-018-0343-9", "ArticleIdList": ["10.1186/s40425-018-0343-9", "PMC6003181", "29907163"]}, {"Citation": "Shimizu K., Funamoto M., Sunagawa Y., Shimizu S., Katanasaka Y., Miyazaki Y., et al. (2019). Anti-inflammatory action of curcumin and its use in the treatment of lifestyle-related diseases. Eur. Cardiol. Rev. 14, 117\u2013122. 10.15420/ecr.2019.17.2", "ArticleIdList": ["10.15420/ecr.2019.17.2", "PMC6659038", "31360234"]}, {"Citation": "Shree P., Mishra P., Selvaraj C., Singh S. K., Chaube R., Garg N., et al. (2020). Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants\u2013Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)\u2013a molecular docking study. J. Biomol. Struct. Dyn. 40, 190\u2013203. 10.1080/07391102.2020.1810778", "ArticleIdList": ["10.1080/07391102.2020.1810778", "PMC7484581", "32851919"]}, {"Citation": "Siddiqi H. K., Mehra M. R. (2020). COVID-19 illness in native and immunosuppressed states: A clinical\u2013therapeutic staging proposal. J. heart lung Transplant. 39, 405\u2013407. 10.1016/j.healun.2020.03.012", "ArticleIdList": ["10.1016/j.healun.2020.03.012", "PMC7118652", "32362390"]}, {"Citation": "Sinha S. K., Prasad S. K., Islam M. A., Gurav S. S., Patil R. B., Alfaris N. A., et al. (2020). Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: A pharmacoinformatics study. J. Biomol. Struct. Dyn. 39, 4686\u20134700. 10.1080/07391102.2020.1779132", "ArticleIdList": ["10.1080/07391102.2020.1779132", "PMC7309308", "32552462"]}, {"Citation": "Song P., Li W., Xie J., Hou Y., You C. (2020). Cytokine storm induced by SARS-CoV-2. Clin. Chim. acta 509, 280\u2013287. 10.1016/j.cca.2020.06.017", "ArticleIdList": ["10.1016/j.cca.2020.06.017", "PMC7283076", "32531256"]}, {"Citation": "Sordillo P. P., Helson L. (2015). Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections. vivo 29, 1\u20134.", "ArticleIdList": ["25600522"]}, {"Citation": "Srivastava V., Yadav A., Sarkar P. (2020). Molecular docking and ADMET study of bioactive compounds of Glycyrrhiza glabra against main protease of SARS-CoV2. Mater. Today Proc. 49, 2999\u20133007. 10.1016/j.matpr.2020.10.055", "ArticleIdList": ["10.1016/j.matpr.2020.10.055", "PMC7556787", "33078096"]}, {"Citation": "Stallmach A., Kortgen A., Gonnert F., Coldewey S. M., Reuken P., Bauer M. (2020). Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure\u2014A cautionary case series. Crit. Care 24 (1), 1\u20133. 10.1186/s13054-020-03158-0", "ArticleIdList": ["10.1186/s13054-020-03158-0", "PMC7366555", "32680535"]}, {"Citation": "Steeland S., Libert C., Vandenbroucke R. E. (2018). A new venue of TNF targeting. Int. J. Mol. Sci. 19, 1442. 10.3390/ijms19051442", "ArticleIdList": ["10.3390/ijms19051442", "PMC5983675", "29751683"]}, {"Citation": "Sun Y., Jiang M., Park P.-H., Song K. (2020). Transcriptional suppression of androgen receptor by 18\u03b2-glycyrrhetinic acid in LNCaP human prostate cancer cells. Archives pharmacal Res. 43, 433\u2013448. 10.1007/s12272-020-01228-z", "ArticleIdList": ["10.1007/s12272-020-01228-z", "32219716"]}, {"Citation": "Tang J., Diao P., Shu X., Li L., Xiong L. (2019). Quercetin and quercitrin attenuates the inflammatory response and oxidative stress in LPS-induced RAW264. 7 cells: In vitro assessment and a theoretical model. BioMed Res. Int., 2019, 7039802. 10.1155/2019/7039802", "ArticleIdList": ["10.1155/2019/7039802", "PMC6855062", "31781635"]}, {"Citation": "Tang L., Yin Z., Hu Y., Mei H. (2020). Controlling cytokine storm is vital in COVID-19. Front. Immunol. 11, 570993. 10.3389/fimmu.2020.570993", "ArticleIdList": ["10.3389/fimmu.2020.570993", "PMC7734084", "33329533"]}, {"Citation": "Thakar A., Panara K., Shah H., Kalsariya B., Ruparel S., Jain N., et al. (2022). Guduchi ghanavati (Ayurveda medication) improves the perceived immunity in individuals at risk of SARS-CoV-2: A multicentred, controlled, before-and-after study. Eur. J. Integr. Med. 53, 102131. 10.1016/j.eujim.2022.102131", "ArticleIdList": ["10.1016/j.eujim.2022.102131", "PMC9047434", "35506012"]}, {"Citation": "Theoharides T. C. (2020). COVID\u201019, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Oxford, England: Biofactors.", "ArticleIdList": ["PMC7267424", "32339387"]}, {"Citation": "Thomas M., Mani R. S., Philip M., Adhikary R., Joshi S., Revadi S. S., et al. (2017). Proinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection. J. Med. virology 89, 1373\u20131381. 10.1002/jmv.24781", "ArticleIdList": ["10.1002/jmv.24781", "28198028"]}, {"Citation": "Toniati P., Piva S., Cattalini M., Garrafa E., Regola F., Castelli F., et al. (2020). Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in brescia, Italy. Autoimmun. Rev. 19, 102568. 10.1016/j.autrev.2020.102568", "ArticleIdList": ["10.1016/j.autrev.2020.102568", "PMC7252115", "32376398"]}, {"Citation": "Tripathi M. K., Singh P., Sharma S., Singh T. P., Ethayathulla A., Kaur P. (2021). Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J. Biomol. Struct. Dyn. 39, 5668\u20135681. 10.1080/07391102.2020.1790425", "ArticleIdList": ["10.1080/07391102.2020.1790425", "PMC7441797", "32643552"]}, {"Citation": "Tripathi S., Maier K. G., Bruch D., Kittur D. S. (2007). Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages. J. Surg. Res. 138, 209\u2013213. 10.1016/j.jss.2006.07.051", "ArticleIdList": ["10.1016/j.jss.2006.07.051", "17291534"]}, {"Citation": "Ulhaq Z. S., Soraya G. V. (2020). Interleukin-6 as a potential biomarker of COVID-19 progression. Med. maladies Infect. 50, 382\u2013383. 10.1016/j.medmal.2020.04.002", "ArticleIdList": ["10.1016/j.medmal.2020.04.002", "PMC7129451", "32259560"]}, {"Citation": "Upadhyay A. K., Kumar K., Kumar A., Mishra H. S. (2010). Tinospora cordifolia (Willd.) Hook. f. and Thoms.(Guduchi)\u2013validation of the Ayurvedic pharmacology through experimental and clinical studies. Int. J. Ayurveda Res. 1, 112\u2013121. 10.4103/0974-7788.64405", "ArticleIdList": ["10.4103/0974-7788.64405", "PMC2924974", "20814526"]}, {"Citation": "Valizadeh H., Abdolmohammadi-Vahid S., Danshina S., Gencer M. Z., Ammari A., Sadeghi A., et al. (2020). Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int. Immunopharmacol. 89, 107088. 10.1016/j.intimp.2020.107088", "ArticleIdList": ["10.1016/j.intimp.2020.107088", "PMC7574843", "33129099"]}, {"Citation": "van de Sand L., Bormann M., Alt M., Schipper L., Heilingloh C. S., Todt D., et al. (2021). Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease. Viruses 13 (4), 609. 10.3390/v13040609", "ArticleIdList": ["10.3390/v13040609", "PMC8066091", "33918301"]}, {"Citation": "Vardhana S. A., Wolchok J. D. (2020). The many faces of the anti-COVID immune response. J. Exp. Med. 217, e20200678. 10.1084/jem.20200678", "ArticleIdList": ["10.1084/jem.20200678", "PMC7191310", "32353870"]}, {"Citation": "Varma A., Padh H., Shrivastava N. (2011). Andrographolide: A new plant-derived antineoplastic entity on horizon. Evidence-Based Complementary Altern. Med., 2011, 1, 9. 10.1093/ecam/nep135", "ArticleIdList": ["10.1093/ecam/nep135", "PMC3139959", "19752167"]}, {"Citation": "Wan S., Yi Q., Fan S., Lv J., Zhang X., Guo L., et al. (2020). Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv."}, {"Citation": "Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. (2020a). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. Jama 323, 1061\u20131069. 10.1001/jama.2020.1585", "ArticleIdList": ["10.1001/jama.2020.1585", "PMC7042881", "32031570"]}, {"Citation": "Wang L., Wang Y., Ye D., Liu Q. (2020b). Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int. J. Antimicrob. agents 55, 105948. 10.1016/j.ijantimicag.2020.105948", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105948", "PMC7156162", "32201353"]}, {"Citation": "Wang Q., Hu Z. (2020). Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification. Int. J. Infect. Dis. 96, 618\u2013620. 10.1016/j.ijid.2020.05.065", "ArticleIdList": ["10.1016/j.ijid.2020.05.065", "PMC7255259", "32470601"]}, {"Citation": "Wang W., Wang J., Dong S.-F., Liu C.-H., Italiani P., Sun S.-H., et al. (2010). Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response. Acta Pharmacol. Sin. 31, 191\u2013201. 10.1038/aps.2009.205", "ArticleIdList": ["10.1038/aps.2009.205", "PMC4002847", "20139902"]}, {"Citation": "Wong S. Y., Tan M. G., Banks W. A., Wong W. F., Wong P. T.-H., Lai M. K. (2016). Andrographolide attenuates LPS-stimulated up-regulation of CC and CXC motif chemokines in rodent cortex and primary astrocytes. J. neuroinflammation 13, 34\u201311. 10.1186/s12974-016-0498-6", "ArticleIdList": ["10.1186/s12974-016-0498-6", "PMC4748554", "26860080"]}, {"Citation": "World Health Organization (2020). Modes of transmission of virus causing COVID-19: Implications for IPC precaution recommendations: Scientific brief, 29 March 2020. China: World Health Organization."}, {"Citation": "Xu X., Han M., Li T., Sun W., Wang D., Fu B., et al. (2020). Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl. Acad. Sci. 117, 10970\u201310975. 10.1073/pnas.2005615117", "ArticleIdList": ["10.1073/pnas.2005615117", "PMC7245089", "32350134"]}, {"Citation": "Yadav R., Jee B., Awasthi S. K. (2015). Curcumin suppresses the production of pro-inflammatory cytokine interleukin-18 in lipopolysaccharide stimulated murine macrophage-like cells. Indian J. Clin. Biochem. 30, 109\u2013112. 10.1007/s12291-014-0452-2", "ArticleIdList": ["10.1007/s12291-014-0452-2", "PMC4310836", "25646051"]}, {"Citation": "Yagi H., Soto-Gutierrez A., Parekkadan B., Kitagawa Y., Tompkins R. G., Kobayashi N., et al. (2010). Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell. Transplant. 19, 667\u2013679. 10.3727/096368910X508762", "ArticleIdList": ["10.3727/096368910X508762", "PMC2957533", "20525442"]}, {"Citation": "Yang L., Liu S., Liu J., Zhang Z., Wan X., Huang B., et al. (2020a). COVID-19: Immunopathogenesis and immunotherapeutics. Signal Transduct. Target. Ther. 5, 128\u20138. 10.1038/s41392-020-00243-2", "ArticleIdList": ["10.1038/s41392-020-00243-2", "PMC7381863", "32712629"]}, {"Citation": "Yang R., Xiong Y., Ke H., Chen T., Gao S. (2020b). The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID\u201019. Eur. J. Clin. investigation 50, e13412. 10.1111/eci.13412", "ArticleIdList": ["10.1111/eci.13412", "PMC7537029", "32954492"]}, {"Citation": "Yang X. H., Sun R. H., Zhao M. Y., Chen E. Z., Liu J., Wang H. L., et al. (2020c). Expert recommendations on blood purification treatment protocol for patients with severe COVID-19. Chronic Dis. Transl. Med. 6 (02), 106\u2013104.", "ArticleIdList": ["PMC7186198", "32346492"]}, {"Citation": "Zahedipour F., Hosseini S. A., Sathyapalan T., Majeed M., Jamialahmadi T., al\u2010Rasadi K., et al. (2020). Potential effects of curcumin in the treatment of COVID\u201019 infection. Phytotherapy Res. 34, 2911\u20132920. 10.1002/ptr.6738", "ArticleIdList": ["10.1002/ptr.6738", "PMC7276879", "32430996"]}, {"Citation": "Zhai W.-J., Zhang Z.-B., Xu N.-N., Guo Y.-F., Qiu C., Li C.-Y., et al. (2016). Piperine plays an anti-inflammatory role in Staphylococcus aureus endometritis by inhibiting activation of NF-\u03baB and MAPK pathways in mice. Evidence-Based Complementary Altern. Med. 2016, 1\u201310. 10.1155/2016/8597208", "ArticleIdList": ["10.1155/2016/8597208", "PMC4880693", "27293467"]}, {"Citation": "Zhang B., Zhou X., Qiu Y., Song Y., Feng F., Feng J., et al. (2020a). Clinical characteristics of 82 cases of death from COVID-19. PloS one 15, e0235458. 10.1371/journal.pone.0235458", "ArticleIdList": ["10.1371/journal.pone.0235458", "PMC7347130", "32645044"]}, {"Citation": "Zhang L., Li Y., Gu Z., Wang Y., Shi M., Ji Y., et al. (2015). Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-\u03baB signaling pathway. PloS one 10, e0116879. 10.1371/journal.pone.0116879", "ArticleIdList": ["10.1371/journal.pone.0116879", "PMC4333343", "25692777"]}, {"Citation": "Zhang M., Pan H., Xu Y., Wang X., Qiu Z., Jiang L. (2017). Allicin decreases lipopolysaccharide-induced oxidative stress and inflammation in human umbilical vein endothelial cells through suppression of mitochondrial dysfunction and activation of Nrf2. Cell. Physiology Biochem. 41, 2255\u20132267. 10.1159/000475640", "ArticleIdList": ["10.1159/000475640", "28456799"]}, {"Citation": "Zhang R., Wang X., Ni L., di X., Ma B., Niu S., et al. (2020b). COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 250, 117583. 10.1016/j.lfs.2020.117583", "ArticleIdList": ["10.1016/j.lfs.2020.117583", "PMC7102583", "32217117"]}, {"Citation": "Zhang X., Zhang Y., Qiao W., Zhang J., Qi Z. (2020c). Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19. International immunopharmacology 86, 106749.", "ArticleIdList": ["PMC7328558", "32645632"]}, {"Citation": "Zhang Y., Yu L., Tang L., Zhu M., Jin Y., Wang Z., et al. (2021). A promising anti-cytokine-storm targeted therapy for COVID-19: The artificial-liver blood-purification system. Eng. (Beijing, China) 7, 11\u201313. 10.1016/j.eng.2020.03.006", "ArticleIdList": ["10.1016/j.eng.2020.03.006", "PMC7118608", "32292628"]}, {"Citation": "Zhao H., Zhao M., Wang Y., Li F., Zhang Z. (2016). Glycyrrhizic acid prevents sepsis-induced acute lung injury and mortality in rats. J. Histochem. Cytochem. 64, 125\u2013137. 10.1369/0022155415610168", "ArticleIdList": ["10.1369/0022155415610168", "PMC4812678", "26385569"]}, {"Citation": "Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature 579, 270\u2013273. 10.1038/s41586-020-2012-7", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Zhou Z. X., Mou S. F., Chen X. Q., Gong L. L., Ge W. S. (2018). Anti-inflammatory activity of resveratrol prevents inflammation by inhibiting NF-\u03baB in animal models of acute pharyngitis. Mol. Med. Rep. 17, 1269\u20131274. 10.3892/mmr.2017.7933", "ArticleIdList": ["10.3892/mmr.2017.7933", "29115472"]}, {"Citation": "Zhu L., Gu P., Shen H. (2019). Gallic acid improved inflammation via NF-\u03baB pathway in TNBS-induced ulcerative colitis. Int. Immunopharmacol. 67, 129\u2013137. 10.1016/j.intimp.2018.11.049", "ArticleIdList": ["10.1016/j.intimp.2018.11.049", "30544066"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "29"}, {"Year": "2023", "Month": "3", "Day": "14"}, {"Year": "2023", "Month": "5", "Day": "1", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "5", "Day": "1", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "1", "Hour": "3", "Minute": "40"}, {"Year": "2023", "Month": "4", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["37124230", "PMC10134036", "10.3389/fphar.2023.1111329", "1111329"]}}], "PubmedBookArticle": []}